Judy Chu Periodic Transaction Report

Filed Jan 21, 2024 · House Clerk · 2 transactions

U.S. Representative · D · CA-28 · All trades by Judy Chu

On January 21, 2024, Rep. Judy Chu (D-CA-28) filed a periodic transaction report with the House Clerk disclosing 2 transactions (1 purchase, 1 sale) dated Jan 10, 2024.

The filing covers 1 ticker, including $AMEH.

Reported amount ranges sum to $200K–$500K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 11 days.

2 transactions were reported under a spouse, dependent child, or joint account rather than the member directly.

Source document: House Clerk filing 20024347

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Judy Chu · Bought $AMEH · Jan 10 · $100K–$250K

0.57MED

Disclosure speedx 0.250.60

Trade sizex 0.250.75

Cluster activityx 0.150.00

Track recordx 0.350.65

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Judy Chu

Get an email the moment Judy Chu files the next one. Free, no card, no spam.

Follow free →

Transactions

1 / 1

Buys / sells

Tickers

11d

Longest lag

Tickers in this filing

AMEH2

Transactions disclosed

Trade date	Ticker	Asset	Type	Owner	Amount	Lag
Jan 10, 2024	AMEH	Apollo Medical Holdings, Inc. (AMEH)	buy	Spouse	$100K–$250K	11d
Jan 10, 2024	AMEH	Apollo Medical Holdings, Inc. (AMEH)	sell	Spouse	$100K–$250K	11d

Other recent filings by Judy Chu

PTR filed Aug 30, 20252 trades · ASTH

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →